MCOV B logo

Medicover AB (publ) Stock Price

OM:MCOV B Community·SEK 31.3b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 12 Fair Values set on narratives written by author

MCOV B Share Price Performance

SEK 206.00
-30.00 (-12.71%)
SEK 257.25
Fair Value
SEK 206.00
-30.00 (-12.71%)
19.9% undervalued intrinsic discount
SEK 257.25
Fair Value
Price SEK 206.00
AnalystConsensusTarget SEK 257.25
AnalystLowTarget SEK 225.02
AnalystHighTarget SEK 307.23

MCOV B Community Narratives

·
Fair Value SEK 257.25 19.9% undervalued intrinsic discount

Demographic Shifts And Digitalization Will Unlock Healthcare Opportunity

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
·
Fair Value SEK 225.02 8.5% undervalued intrinsic discount

Rising European Labor Costs And Regulatory Burdens Will Squeeze Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value SEK 307.23 32.9% undervalued intrinsic discount

Digitalization And Diagnostics Will Unlock Secular Private Healthcare Growth

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
SEK 225.02
8.5% undervalued intrinsic discount
Revenue
11.44% p.a.
Profit Margin
4.97%
Future PE
22.8x
Price in 2029
SEK 261.23
SEK 307.23
32.9% undervalued intrinsic discount
Revenue
13.42% p.a.
Profit Margin
6.71%
Future PE
21.71x
Price in 2029
SEK 356.7

Trending Discussion

Updated Narratives

MCOV B logo

MCOV B: Stable Assumptions And P/E Outlook Will Support Future Upside Potential

Fair Value: SEK 257.25 19.9% undervalued intrinsic discount
6 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
MCOV B logo

MCOV B: Dividend Plans And 2028 Revenue Aims Will Shape Fair Outlook

Fair Value: SEK 225.02 8.5% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
MCOV B logo

MCOV B: Dividend Policy And 2028 Revenue Ambition Will Drive Future Upside

Fair Value: SEK 307.23 32.9% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

High growth potential with proven track record.

1 Risk
4 Rewards

Medicover AB (publ) Key Details

€2.4b

Revenue

€1.9b

Cost of Revenue

€565.2m

Gross Profit

€485.7m

Other Expenses

€79.5m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Jul 22, 2026
0.52
23.31%
3.28%
153.0%
View Full Analysis

About MCOV B

Founded
1995
Employees
49000
CEO
John Stubbington
WebsiteView website
www.medicover.com

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company operates through two segments: Healthcare Services and Diagnostic Services. Its Healthcare Services include outpatient and inpatient care; dental care, mental health care, orthopedics, preventive plans and sports, and wellness; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company’s Diagnostic Services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public sector clients. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

Recent MCOV B News & Updates

Narrative Update Jun 17

MCOV B: Stable Assumptions And P/E Outlook Will Support Future Upside Potential

The analyst price target for Medicover has been reaffirmed at SEK257.25, with only minor model tweaks to the discount rate, revenue growth, profit margin and future P/E. These changes reflect updated analyst assumptions rather than a shift in the overall valuation view.
Narrative Update Jun 02

MCOV B: Lower Discount Rate Will Support Future Upside Potential

Analysts have nudged their Medicover price target slightly higher to around SEK257 per share, reflecting minor adjustments to the discount rate, revenue growth, profit margin and future P/E assumptions in their models. What's in the News No recent company specific news items, periodical coverage or key developments were provided for Medicover in the supplied sources.

Recent updates

No updates